MitoCanada

Silencing Mitochondrial Gene Expression in Living Cells

Science moves fastest when everyone can take part. That’s why MitoCanada is committed to empowering our community with knowledge. By translating cutting-edge mitochondrial research into clear, easy-to-understand summaries, we aim to nurture curiosity, strengthen understanding, and build confidence in the science driving hope and progress.

Lay Summary: Silencing Mitochondrial Genes Expression in Living Cells

Authors:

Cruz-Zaragoza, L.D., Andree, M., Richter-Dennerlein, R., Mårtensson, C.U., Deimling, L., Culley, S., Peter, B., Grzyb, K., Silvander, C., Lindberg, M., Zickermann, V., Arlt, H., Schliebs, W., Amunts, A., Spåhr, H., Spang, A., Rugarli, E.I., Wiedemann, N., Callegari, S., Larsson, N.-G., and Dennerlein, S.

What’s this research about?

Every cell in our body contains mitochondria, tiny structures that act like power plants, producing the energy our bodies need to function.
Mitochondria have their own small set of genes, separate from the DNA in the cell’s nucleus. Understanding what these mitochondrial genes do is crucial for discovering how energy production works and why it sometimes fails in mitochondrial disease.

Until now, scientists had no reliable way to “turn off” or silence specific mitochondrial genes inside living cells. This made it hard to study exactly how each gene affects mitochondrial function.

This study, led by Dr. Luis D. Cruz-Zaragoza and colleagues, reports a new method that allows researchers to selectively silence mitochondrial genes in living cells, giving them a powerful tool to study how those genes work.

What are mitochondria and why do they matter?

Understanding what each mitochondrial gene does is essential to uncovering how mitochondrial function normally, and what goes wrong when they don’t.

Many mitochondrial diseases are caused by mutations in mitochondrial DNA, but because researchers haven’t been able to directly study how each gene contributes to energy production, it has been difficult to pinpoint exactly how these mutations lead to disease.

This new tool fills an important gap. It doesn’t treat or repair mitochondrial DNA, but it gives scientists a much clearer way to study the function of each gene and how its loss affects the cell. With this knowledge, researchers can build a more complete picture of how mitochondrial dysfunction develops, paving the way for more targeted investigations in the future.

How did they study this?

The researchers found that their new approach could precisely and temporarily silence individual mitochondrial genes inside living cells. When they silenced specific genes, the cells showed clear changes in their energy production and mitochondrial performance.

These results confirmed that the tool worked as intended and that its effects were specific, rather than causing broad or unintended changes elsewhere in the cell.

This discovery shows that mitochondrial gene activity can now be studied in far greater detail than before, offering a more direct way to link specific genes to their roles in energy metabolism and cell health.

What does this mean for mitochondrial disease research?

While this study does not present a therapy or treatment, it provides a vital new research tool that will help scientists understand the underlying biology of mitochondrial diseases.

By using this approach, researchers can better study how individual gene defects disrupt energy production and how cells respond when key mitochondrial proteins are missing. This deeper level of insight can improve laboratory models of disease and guide future studies that seek to correct or compensate for mitochondrial dysfunction.

In short, this work equips the scientific community with a new way to explore the basic building blocks of mitochondrial biology, a necessary step before effective therapies can be developed

In simple terms

This study introduces a way for scientists to switch off one mitochondrial gene at a time in living cells and watch what happens next. It’s like being able to press pause on one tiny part of the mitochondria’s instruction manual to see how important that page is to the overall power plant. By doing this, researchers can learn more precisely how mitochondria make energy and what goes wrong when certain genes don’t work properly.

Why this matters to the MitoCommunity

For people living with mitochondrial disease, this type of research represents progress at the foundation level, the kind of work that helps scientists truly understand how mitochondria function and fail. By improving the tools used to study these essential genes, the scientific community can generate stronger evidence, create more accurate disease models, and design better studies in the years ahead.

While this discovery is not a treatment, it strengthens the path toward one. Every improvement in understanding how mitochondria work brings researchers, patients, and families closer together in the shared effort to one day find solutions for mitochondrial disease.

Acknowledgment

This research was led by Dr. Luis D. Cruz-Zaragoza and Dr. Stefan Dennerlein, with contributions from an international team of scientists including Dr. Nils-Göran Larsson, Dr. Simona Callegari, Dr. Elena Rugarli, and collaborators across Sweden, Germany, and Italy. Together, their work represents a major collaborative effort to expand the scientific tools available for studying mitochondrial gene function in living cells.

Explore the orginial publication or download our layperson article today:

Do you have a question about this article? If so, we’d like to hear from you. Please send us an email!

Mitochondrial-Targeted Therapy Prevents Early Onset Muscle Weakness in Ovarian Cancer

Science moves fastest when everyone can take part. That’s why MitoCanada is committed to empowering our community with knowledge. By translating cutting-edge mitochondrial research into clear, easy-to-understand summaries, we aim to nurture curiosity, strengthen understanding, and build confidence in the science driving hope and progress.

Lay Summary: Mitochondrial-Targeted Therapy Prevents Early Onset Muscle Weakness in Ovarian Cancer

Authors:
Luca J. Delfinis¹†, Shahrzad Khajehzadehshoushtar¹†, Luke D. Flewwelling¹, Nathaniel J. Andrews¹, Madison C. Garibotti¹, Shivam Gandhi¹, Aditya N. Brahmbhatt¹, Brooke A. Morris¹, Bianca Garlisi², Sylvia Lauks², Caroline Aitken², Leslie Ogilvie⁴, Stavroula Tsitkanou³, Jeremy A. Simpson⁴, Nicholas P. Greene³, Arthur J. Cheng¹, Jim Petrik², and Christopher G.R. Perry¹*

What’s this research about?

This study explored how mitochondrial health affects muscle strength during cancer, and whether a special antioxidant therapy could protect muscles from weakening. The research team focused on ovarian cancer, which often causes cachexia, a condition where muscles waste away, leading to fatigue, weakness, and poor quality of life.

But the scientists made an important discovery: muscle weakness actually starts before muscles shrink or lose size. That means something other than muscle loss, such as mitochondrial dysfunction, might be the early cause of this weakness.

What are mitochondria and why do they matter?

Mitochondria are the “power houses” inside our cells. They generate the energy (ATP) that our muscles need to contract and function. When they’re damaged or stressed, as often happens in cancer, they can produce too many reactive oxygen species (ROS), or “free radicals.” These molecules can damage cells and lead to fatigue and weakness.

The big question

Can improving mitochondrial health before muscle loss occurs protect strength in people with cancer?

How did they study this?

The research team used a mouse model (a research method using mice that share important biological similarities with humans) of ovarian cancer that closely mimics how the disease progresses in humans. They treated some mice with a compound called SkQ1, a mitochondria-targeted antioxidant that acts like a shield inside the mitochondria, reducing oxidative stress and helping mitochondria function better.

They tested:

  • Muscle strength in both the legs and the diaphragm (breathing muscle)
  • Mitochondrial energy production and oxygen use
  • Signs of inflammation and oxidative stress

What did they find?

  • Muscle weakness happened early, even before the muscles showed signs of shrinking (atrophy).
  • SkQ1 helped preserve muscle strengthin both early and late stages of cancer.
  • SkQ1 did not stop muscle loss, but it made muscles stronger and more efficient despite atrophy.
  • The therapy improved calcium handling inside muscle cells, helping them contract properly. Calcium handling refers to how muscle cells control the movement of calcium, an essential mineral that acts like an on/off switch for muscle contraction.
  • The positive effects were linked to healthier mitochondria, less oxidative stress and more stable energy metabolism.

In short, SkQ1 helped keep muscles “powered up” longer, even while cancer progressed.

Why is this important?

This is one of the first studies to show that muscle weakness and muscle wasting are not the same thing, and that mitochondria play a key role in strength loss during cancer.

By targeting mitochondria directly, scientists may be able to:

  • Delay or reduce early weakness that affects mobility and breathing
  • Improve quality of life for people living with cancer
  • Potentially make the body more resilient during cancer treatment

What could this mean for future therapies?

The findings highlight mitochondria as a promising therapeutic target for cancer-related muscle weakness.
If similar results can be confirmed in humans, mitochondrial-targeted therapies like SkQ1 (or similar compounds such as MitoQ and SS-31) could one day:

  • Help people maintain strength and independence during cancer
  • Complement existing treatments
  • Improve recovery and energy balance in other diseases linked to mitochondrial dysfunction

 In simple terms

Cancer doesn’t just cause muscles to shrink, it makes them weak by hurting their mitochondria first. This research shows that by protecting the mitochondria early, we might keep muscles stronger for longer, even in the face of disease.

Why this matters to the MitoCommunity

This study deepens our understanding of how mitochondrial dysfunction contributes to weakness and fatigue, symptoms shared by people with mitochondrial disease. It reinforces that muscle health depends on mitochondrial health, and that therapies aimed at stabilizing mitochondrial function can have far-reaching benefits, not just for cancer patients but for anyone affected by energy metabolism disorders.

For the MitoCommunity, this research offers hope that the same principles, protecting mitochondria to preserve strength and energy, could one day be applied to treating mitochondrial diseases directly.

Acknowledgment

This research was led by Dr. Christopher G.R. Perry at York University’s Muscle Health Research Centre, with contributions from Luca J. Delfinis, Shahrzad Khajehzadehshoushtar, Dr. Jim Petrik, Dr. Nicholas Greene, and colleagues from York University, the University of Guelph, and the University of Arkansas.

Their collaborative work provies new insight into how protecting mitochondrial health can help preserve muscle strength during cancer progression, deepening scientific understanding of the relationship between mitochondrial function and muscle health.

Explore the orginial publication or download our layperson article today:

Do you have a question about this article? If so, we’d like to hear from you. Please send us an email!

15 Stories for 15 Years: Meet Kailey Danks

As we celebrate 15 years of MitoCanada, we’re sharing the stories of those who make this community so special. Today, we’re sharing the story of Kailey Danks from Ajax, Ontario.

Kailey lives in Ajax with her husband and two kids. Her diagnosis journey began in childhood and stretched over seven years, finally leading to a general mitochondrial disease diagnosis after a muscle biopsy. ⁠

“Receiving a mitochondrial disease diagnosis is scary and challenging,” she shares. “With my condition I’ve experienced ptosis (droopy eyelid) and have had four surgeries along with vision loss, chronic pain, respiratory issues, and muscle weakness. But I really appreciate the support and resources I’ve accessed through MitoCanada.”

A pivotal moment came when Kailey connected with Dr. Mark Tarnopolsky and received a diagnosis of CPEO+. In his office, she noticed a poster about MitoCanada, and that connection changed everything.⁠

Through MitoCanada, Kailey became a peer support volunteer and attended the very first mitochondrial disease conference in Canada. She was also provided financial support to attend the UMDF conference in the U.S. “These conferences were life-changing for me as I met others with similar experiences and felt connected and supported,” she says.

Today, Kailey is proud to serve as a MitoCanada mitoAmbassador. “I’m very happy that I’ve just accepted this role,” she says. “I’m looking forward to sharing my story and raising awareness about MitoCanada and mitochondrial disease within my community.”

We’re grateful to Kailey for her courage, her advocacy, and her inspiring commitment to supporting others in the MitoCommunity.

Join us in fuelling the next 15 years. Every donation helps us continue this vital work and create a future where no one faces mito alone.

Be part of the journey. Donate today:

15 Stories for 15 Years: Meet Kim Good

As we celebrate 15 years of MitoCanada, we’re sharing the stories of those who make this community so special. Today, we’re highlighting Kim Good and Angelina, Free Spirit Woman of the Eagle Clan

Born on June 1, 2003, Angelina Good was a fighter from the start. Born at 32 weeks because her mom, Kim, was diagnosed with placenta previa, she spent her first two months in hospital. Angelina was born deaf in one ear, but she never let challenges hold her back. She loved animals, camping, fishing, horseback riding, soccer, skating, art, crafts, writing short stories, reading, and celebrating her Métis heritage. Horses, especially, made her feel “free and happy.” Friends and family often described her as “an old soul.”

“Angelina had a happy and mostly normal childhood,” says Kim. “She did have many health issues that we now believe were misdiagnosed, misunderstood, and undiagnosed.”

In 2017, Angelina had her first seizure, followed by a stroke the next year that left her wheelchair-bound. “We were all shocked and distraught because we had no idea what was happening or how to help her,” says Kim. “We were helpless and clueless, and our hearts shattered. She went from being an independent teenager to requiring someone with her 24/7. Her big sister Leah stepped in to help raise and care for Angelina, especially during times when I faced health issues.”

After initially being misdiagnosed with epilepsy, Angelina was eventually diagnosed with MELAS (mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes) by Dr. Samantha Marin, a Winnipeg-based pediatric neurologist and member of MitoCanada’s Research and Clinical Advisory Committee.

For Kim and her family, the diagnosis brought heartbreak, and while it did bring some answers, it also brought more questions. “We had never heard of this disease,” says Kim. “We’ve come to learn that MELAS is a rare, maternally inherited mitochondrial disorder that affects the nervous system and muscles. It’s characterized by lactic acidosis, stroke-like episodes, and encephalopathy (brain dysfunction). But what exactly did that mean for her, and for us as her caregivers and family?”

In 2019, Dr. Marin suggested they reach out to MitoCanada, which helped the family attend the fall mitoConference, co-hosted by MitoCanada and MitoNet in Toronto, Ontario. “It was overwhelming, but we came home with loving connections and a wealth of knowledge,” Kim says. “We also received guidance and information for other family members. Because of our warrior Angelina, our family now has knowledge to share for generations to come. I was adopted as a baby, so I grew up without access to my biological family’s medical history. That made Angelina’s journey to diagnosis even more complex, since we had no history to help connect the dots. As an adult, I reconnected with my birth family and discovered that many of my relatives had health issues that were likely misdiagnosed. Earlier this year, my older sister was formally diagnosed with MELAS, which confirms that this disease runs through my maternal line. Now I’ve been able to share this vital information with relatives across Canada, helping them seek proper diagnoses and care. This disease truly affects my entire family.”

Just three months before her passing in February 2025, Angelina received her spirit name, Free Spirit Woman of the Eagle Clan, in a powerful moment that reflected her Métis heritage. “She embraced this wholeheartedly,” says Kim.

Kim continues to raise awareness in Angelina’s honour: lighting up her balcony with bright green lights for World Mitochondrial Disease Week, wearing two custom mito T-shirts her oldest daughter had made for her and a mito pendant necklace she won in a MitoCanada social media giveaway (“People always ask what it means,” she says), and sharing the message she wants every family to hear: “You are not alone. It is a long, tough battle, but you are not alone.” She works hard to spread awareness however she can. “MitoCanada makes it easy with their website, social media, and events,” she adds. “MitoCanada and the MitoCommunity have been there through some of the hardest times, always providing a reply, an ear to listen, and new and hopeful information.”

We’re grateful to Kim and her family for their courage and for inspiring our MitoCommunity by sharing Angelina’s story and spirit. Kim also shares that Leah helped write Angelina’s story, ensuring her sister’s spirit lives on through her words.

Join us in fuelling the next 15 years. Every donation helps us continue this vital work and create a future where no one faces mito alone.

Be part of the journey. Donate today:

15 Stories for 15 Years: Meet Jayda Back

As we celebrate 15 years of MitoCanada, we’re sharing the stories of those who make this community so special. Today, we’re highlighting Jayda Back and her son, mighty Decklan!

Jayda is the proud mom of a remarkable 12-year-old boy living with mitochondrial disease. Decklan was diagnosed with Leigh syndrome at the age of five — a diagnosis that, as Jayda describes, “rocked our family’s world.” At the time, they didn’t even know what mitochondrial disease was.

Despite the devastating diagnosis, Decklan continues to defy the odds and thrive. “Life is not easy for him,” Jayda says, “but he never lets his disease stop him from trying everything.” Since day one, their family’s goal has been to give Decklan a full life — making memories every chance they have.

Jayda appreciates that MitoCanada is so invested in supporting families affected by mito. “From information about new studies and testing, to facts about mito diseases, to sharing stories about those that are affected, to fun contests and giveaways, I really appreciate it all,” she says.

Although she had heard of MitoCanada after Decklan’s diagnosis, it wasn’t until she met Richard and Megan MacDonald — some of MitoCanada’s biggest ambassadors! — at a booth during the Regina Queen City Marathon that she felt truly connected. “After meeting them, I became connected to others in the community,” says Jayda. “Being a part of this community has given us lifelong friends and connections who truly understand what we’re going through and support us unconditionally.”

Jayda has also been an incredible champion for MitoCanada. “Anytime I can bring awareness to MitoCanada and the amazing work the organization does, it makes me proud,” she says. “The more awareness we get, the more chance we’ll be able to find cures for our children and loved ones down the road.”

Jayda’s message to others in the MitoCommunity is simple: “I hope everyone who lives with mito, or is a caregiver of someone who is, takes care of themselves and truly lives every day to its fullest.”

We’re grateful to Jayda Back and family for being such an inspiring part of our MitoCommunity.

Join us in fuelling the next 15 years. Every donation helps us continue this vital work and create a future where no one faces mito alone.

Be part of the journey. Donate today:

15 Stories for 15 Years: Meet Leeanne Wilson

As we celebrate 15 years of MitoCanada, we’re sharing the stories of those who make this community so special. Today, we’re highlighting Leeanne Wilson and her son, Tanner.

Tanner was the baby who completed Leeanne and Patrick Wilson’s family. After a full-term pregnancy and normal delivery, they brought him home to join his big brother, Nolan. But as Tanner grew, they began to notice he wasn’t hitting his developmental milestones. He was slower to walk and talk and had mild eye abnormalities.

Like many parents, Leeanne and Patrick sought answers through countless medical visits. After a fall sent Tanner to the ER, an MRI was completed and they received a devastating diagnosis: Leigh syndrome, a rare mitochondrial disease. “We had never even heard of it,” says Leeanne. “When we googled it, we read that Tanner could have as little as two months or up to five years to live to the fullest. That was very hard to unread — and impossible to accept.”

Determined to learn more, Patrick began researching and came across Dr. Aneal Khan in Calgary, who agreed to see Tanner. The family travelled there from their home in Saskatoon. There, after additional tests, they learned that Tanner had Complex 1 Deficiency with Leigh symptoms, caused by his MT-ND6 gene. “We travelled home from Calgary that first time feeling a little less heavy, having more information about Tanner, but still wondering how we would navigate this ‘new normal,’” says Leeanne.

It was Dr. Khan who suggested they connect with MitoCanada and attend an upcoming conference. “That was when I found my tribe,” Leeanne shares. “A group of like-minded, like-confused, hopeful, and questioning people who understood what we were going through and could help our family navigate these rough waters called mito.”

Through MitoCanada, the Wilsons discovered they were not alone. “This group helped us realize we weren’t isolated,” says Leeanne. “Sometimes the support took the shape of a physical aid for Tanner or just a compassionate shoulder to cry on. We were surrounded by other parents all hoping, wishing, and praying for one another and for their own child.”

Today, Tanner is 12 years old and continues to amaze his family with his strength and spirit. “He is a strong warrior, a determined young man who, despite the challenges of mito, approaches life with remarkable resilience,” Leeanne says. “His spirit shines through his daily battles, teaching us invaluable lessons about courage, perseverance, and the true meaning of life.”

Wanting to raise awareness, the Wilsons organized their first Mito Glow Walk in Saskatoon during World Mitochondrial Disease Week. Friends, family, and members of the community dressed in bright green and glowing gear gathered to walk for Tanner and all the mito warriors who have fought or continue to fight this disease. The Wilsons plan to make it an annual tradition.

Leeanne says the support and resources MitoCanada provides have been invaluable. “MitoCanada continues its mission to bring awareness to a disease most have never heard of,” she says. “We’re so grateful for this inspiring and supportive community.”

Leeanne, Tanner, and the entire Wilson family inspire us with their strength, love, and determination. We’re grateful to have them as such an important part of our MitoCommunity.

Join us in fuelling the next 15 years. Every donation helps us continue this vital work and create a future where no one faces mito alone.
Be part of the journey. Donate today:

Hazel’s Light Up for Mito Walk

Hazel's Light Up for Mito Walk

Thank you to all the Vancouver Island families and supporters living with mitochondrial disease for joining the 3rd annual Hazel’s Light Up for Mito Walk! This annual walk is led by MitoCanada’s mitoAmbassador Hazel Currie, who lives with MNGIE (mitochondrial neurogastrointestinal encephalopathy), an ultra-rare mitochondrial disease. While thousands of Canadians live with mitochondrial disease, Hazel remains the only known case of MNGIE in British Columbia and is using her energy to help raise awareness, inspire hope and educate others about mito. 

Photograph of the fountain in front of the BC Legislative Building lit green for Hazel's Light Up for Mito Walk 2024Event Details

On Saturday, September 20th, 2025 Hazel led the group for a stroll through downtown Victoria, taking in the 15 heritage buildings and local businesses glowing green. The walk started at Christ Church Cathedral and ended at the BC Legislatures, where the ceremonial entrance alcove and fountains were lit in vibrant green in support of mitochondrial disease awareness. Details for 2026 will be announced soon.

Landmark Address City Date of Light Up
BC Ferries The Atrium - 800 Yates Street Victoria September 20th
Cascadia Architects 101-804 Broughton Street Victoria September 20th
Christ Church Cathedral 930 Burdett Avenue Victoria September 20th
Discovery Coffee 1001 Blanshard Street Victoria September 20th
DT YMCA-YWCA 851 Broughton Street Victoria September 20th
Fort Properties 814 Broughton Street Victoria September 20th
Legislative Assembly of BC 501 Belleville Street Victoria September 20th
Oak Bay Municipal Hall 2167 Oak Bay Avenue Victoria September 20th
St Andrew's Presbyterian Church 680 Courtney Street Victoria September 20th
Strathcona Hotel 919 Douglas Street Victoria September 20th
Theatre SKAM 849 Fort Street Victoria September 20th
Royal Theatre 805 Broughton Street Victoria September 20th
Superflux {Cabana} 804 Broughton Street Victoria September 20th
Urban Smiles 823 Broughton Street Victoria September 20th
Victoria City Hall 1 Centennial Square Victoria September 20th

15 Stories for 15 Years: Meet Louise Gibson

As we celebrate 15 years of MitoCanada, we’re sharing the stories of those who make this community so special. Today, we’re highlighting Louise Gibson (@mymitojourney) — a passionate advocate, mitoAmbassador, and founder of Walk N’ Roll 4 Mito.

Louise began experiencing symptoms of mitochondrial disorder as a child — unexplained muscle fatigue and weakness. Her teachers misunderstood, and a gym teacher even told Louise’s mother that “Louise isn’t trying.” But her mother knew better. Louise’s attitude was always about doing her best. Eventually, she was referred to a neurology clinic in Montreal, and at age 18, she was finally diagnosed with mitochondrial disorder. At age 27, Louise was treated at McMaster Hospital. It’s at that time that her older sister Rita, who had been misdiagnosed with cerebral palsy at birth, was also diagnosed with mitochondrial disorder.

It took another 18 years to determine that both sisters had the TRMT5 deficiency. There were only two other known cases globally.

Living with mito hasn’t been easy, but Louise remains deeply committed to finding light and purpose. Her two adult children are unaffected by the disease. Louise is grateful for the unwavering support of all her family and friends.

Louise has never stopped giving back — whether it’s volunteering with Trillium Health Partners and Special Olympics Canada, sharing her lived experience with health care teams, or serving as a dedicated mitoAmbassador for MitoCanada. She also stays active with aquafit, which she calls her “medicine,” helping her manage mito and feel her best.

In 2015, Louise founded Walk N’ Roll 4 Mito in Mississauga, Ont., after participating in another walk for mito, where she realized she was the only person with mito walking the route. “When I finally finished, I was 40 minutes behind everyone else, and all the finishers were still there cheering me on,” she says. “The encouragement was so inspiring!” That moment sparked something big. Walk N’ Roll 4 Mito has since grown into a powerful, nationwide movement — and 2025 marks its 10th anniversary.

Louise now dedicates each walk to her sister Rita, who lost her battle with mito, and to all the lives lost too soon to mitochondrial disorder. “I want to show that doing something is better than nothing, and the more you push yourself, the better you feel,” she says. “Exercise is medicine, especially with mito disorders. Even though I can’t walk far anymore, I do what I can.”

Through her advocacy with MitoCanada, Louise hopes to see the organization continue building its strong foundation — expanding community support even further, and finding new ways to help improve the daily life for those living with mito.

She’s also passionate about raising awareness and funds for research. “It would have made a difference in my life and my sister Rita’s,” she says. “We may not have a cure yet — and I’m too old to benefit from mitochondrial transplantation — but the science is getting there.”

“I know I have mito,” Louise adds, “but mito doesn’t have me!”

Join us in fuelling the next 15 years. Every donation helps us continue this vital work and create a future where no one faces mito alone.
Be part of the journey. Support Louise’s MitoJourney today:

15 Stories for 15 Years: Meet Linda Pilon

As we celebrate 15 years of MitoCanada, we’re sharing the stories of those who make this community so special. Today, we’re highlighting Linda Pilon — passionate mito advocate, retired nurse, founder of Scott’s Ride and loving mom to Scott.

Linda’s journey with mitochondrial disease began in the late 1970s, when her son Scott started experiencing unexplained symptoms. At just 4 years old, Scott would sometimes get sick after swimming, biking, or gym class. As he grew older, his symptoms worsened — including headaches, failure to gain weight, seizures, and strokes that left him blind. At age 11, Scott underwent surgery for a brain tumour that was found to be non-cancerous. Sadly, he passed away shortly after a muscle biopsy was conducted.⁠

At the time, mitochondrial disease was virtually unknown. “In 1985, Scott’s doctor shared an article with me about MELAS, a rare mitochondrial condition,” Linda recalls. “He said he only knew of three cases — one in BC and two in New York.”⁠

Determined to raise awareness and honour her son’s legacy, Linda created @Scott’s Ride in 2012 — cycling with her daughter Debbie from Keremeos, BC to Toronto, ON to support mito research and awareness. “I had to do something,” she says. “There were so many people who didn’t even know what mitochondrial disease was.”

Since then, Linda and Debbie have organized rides, spin events, and community outreach — including awareness efforts in Kamloops, BC (including securing proclamations for World Mitochondrial Disease Week), spin events in Penticton, and participation in the Granfondo in Penticton. ⁠

What inspires her most about MitoCanada? “It gives people hope,” says Linda. “It connects you with others so you know you’re not alone.”

Linda’s message to the MitoCommunity? “Never give up. Keep searching for answers,” she says. “The sooner mito is diagnosed, the sooner it can be treated. More research and awareness brings us closer to a cure.”

Join us in fuelling the next 15 years. Every donation helps us continue this vital work and create a future where no one faces mito alone.
Be part of the journey. Donate today:

15 Stories for 15 Years: Meet Cheryl Lowery

As we celebrate 15 years of MitoCanada, we’re sharing the stories of those who make this community so special. Today, we’re highlighting Cheryl Lowery — founder of @Be There Races and a dedicated supporter of MitoCanada since 2016.

When Cheryl launched Be There Races, she knew she wanted to align her events with a meaningful cause. “Knowing Blaine and the huge involvement that MitoCanada has in the running community, it was a natural fit,” she shares.

Since then, Be There Races has been raising funds through events in support of MitoCanada — and one event in particular holds a special place in Cheryl’s heart.

“In 2017, we started a sprint triathlon and duathlon called ‘Tri for Evan,’ named for Blaine and Sarah’s son,” she says. “Over the years, we’ve had hundreds of people participate and raise funds for MitoCanada. Blaine, Sarah, and Evan even participated some years. It was always such a great pleasure to have the whole Penny family at the race.”

This year, Tri for Evan 2025 will be the grand finale — a celebration of Evan’s legacy and the impact this event has had.

Cheryl’s message to the MitoCommunity? “Keep on moving!”

Want to keep moving this summer? Sign up for Tri for Evan on June 7th and be part of something meaningful.

Join us in fuelling the next 15 years. Every donation helps us continue this vital work and create a future where no one faces mito alone.
Be part of the journey. Donate today:

Go to Top